{
    "name": "brimonidine topical",
    "comment": "Rx",
    "other_names": [
        "Mirvaso"
    ],
    "classes": [
        "Acne Agents",
        "Topical",
        "Alpha Agonists",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/mirvaso-brimonidine-topical-999878",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Unknown if distributed in human breast milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Unknown if distributed in human breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or SjÖgren’s syndrome",
                "Alpha-2 adrenergic agents can lower blood pressure; caution with severe or unstable/uncontrolled cardiovascular disease",
                "Serious adverse reactions may occur following accidental ingestion of alpha-2 agonists by children; keep out of reach of children",
                "Not for oral, ophthalmic, or intravaginal use",
                "Erythema involving areas of face previously not affected by erythema and areas (e.g., neck and chest) outside of treatment sites reported",
                "Treatment effect of topical gel may begin to diminish hours after application",
                "Increased frequency of flushing and/or erythema with flushing following gel application reported",
                "Pallor or excessive whitening at or outside application site, following treatment with topical gel.reported",
                "Allergic contact dermatitis reported",
                "Hypersensitivity reactions following gel application include angioedema, throat tightening, tongue swelling, and urticaria; Institute appropriate therapy and discontinue therapy, if clinically significant hypersensitivity reaction occurs"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Flushing",
            "percent": "10"
        },
        {
            "name": "Erythema",
            "percent": "8"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "5"
        },
        {
            "name": "Skin",
            "percent": "4"
        },
        {
            "name": "burning sensation",
            "percent": "4"
        },
        {
            "name": "Increased intraocular pressure",
            "percent": "4"
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Cardiovascular disorders",
            "percent": null
        },
        {
            "name": "Bradycardia",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "including orthostatic hypotension",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "hypersensitivity",
            "percent": null
        },
        {
            "name": "lip swelling",
            "percent": null
        },
        {
            "name": "swollen tongue",
            "percent": null
        },
        {
            "name": "throat tightness",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous disorders",
            "percent": null
        },
        {
            "name": "Pallor",
            "percent": null
        }
    ]
}